Back to Market Feed

TOSYMRA 10 MG NASAL SPRAY

Sumatriptan
$108.1540per EA
High Outlier

Strength

10 mg/.1mL

NDC

70792081261

Classification

Brand

Dosage Form

SPRAY

Route

NASAL

Last Updated

4/22/2026

Active Ingredients

SUMATRIPTAN

Approval Type

New Drug (NDA)

FDA Application

NDA210884

On Market Since

7/1/2023

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price History

1W

0.0%

1M

+0.2%

3M

+0.3%

6M

-0.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MAXALT MLT 10 MG TABLET
Brand
78206014301•Organon LLC
$44.3130
per EA
MAXALT 10 MG TABLET
Brand
78206014201•Organon LLC
$44.4765
per EA
IMITREX 100 MG TABLET
Brand
00173073701•GlaxoSmithKline LLC
$72.5313
per EA
IMITREX 50 MG TABLET
Brand
00173073601•GlaxoSmithKline LLC
$73.0682
per EA
RELPAX 40 MG TABLET
Brand
00049234005•Roerig
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036856•Viatris Specialty LLC
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036896•Viatris Specialty LLC
$77.1492
per EA
RELPAX 20 MG TABLET
Brand
00049233045•Roerig
$77.3165
per EA
RELPAX 20 MG TABLET
Brand
58151036756•Viatris Specialty LLC
$77.3165
per EA
TOSYMRA 10 MG NASAL SPRAY
Brand
00245081261•Upsher-Smith Laboratories LLC
$108.1537
per EA